CervoMed Inc. Common Stock earnings per share and revenue
On 07 de nov. de 2025, CRVO reported earnings of -0.84 USD per share (EPS) for Q3 25, missing the estimate of -0.78 USD, resulting in a -6.68% surprise. Revenue reached 322.57 mil, compared to an expected 1.45 milhão, with a -77.68% difference. The market reacted with a -0.29% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 analistas forecast an EPS of -0.63 USD, with revenue projected to reach 986.00 mil USD, implying an diminuir of -25.00% EPS, and aumentar of 205.67% in Revenue from the last quarter.
FAQ
What were CervoMed Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, CervoMed Inc. Common Stock reported EPS of -$0.84, missing estimates by -6.68%, and revenue of $322.57K, -77.68% below expectations.
How did the market react to CervoMed Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -0.29%, changed from $6.92 before the earnings release to $6.90 the day after.
When is CervoMed Inc. Common Stock expected to report next?
The next earning report is scheduled for 16 de mar. de 2026.
What are the forecasts for CervoMed Inc. Common Stock's next earnings report?
Based on 9
analistas, CervoMed Inc. Common Stock is expected to report EPS of -$0.63 and revenue of $986.00K for Q4 2025.